申请人:NIHON NOHYAKU CO., LTD.
公开号:EP0761658A1
公开(公告)日:1997-03-12
The present invention relates to azole-phenyl urea derivatives represented by the general formula (I):
[wherein each of R1, R2 and R3 is H, halogen, C1-8alkyl or the like, and A is a group represented by the formula (i) or (ii):
(wherein R4, R5, R6 and X are as defined in the specification.)] and a pharmacologically acceptable salt thereof, which have ACAT-inhibitory activity and are useful as a prophylactic and therapeutic agent for hypercholesterolemia, atherosclerosis and various diseases caused by them; a process for producing said derivative; and an ACAT inhibitor containing said derivative or salt as an active ingredient.
本发明涉及一种由通式(I)表示的唑-苯基脲衍生物:
[其中R1、R2和R3中的每一个是H、卤素、C1-8烷基或类似物,A是由式(i)或(ii)表示的基团:
(其中R4、R5、R6和X如规范中定义。)]及其药理学上可接受的盐,具有ACAT抑制活性,并可用作高胆固醇血症、动脉粥样硬化及由其引起的各种疾病的预防和治疗剂;生产该衍生物的方法;以及含有该衍生物或盐作为活性成分的ACAT抑制剂。